Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer

BACKGROUND: Increasing evidence has revealed an important role of versican (VCAN) on various aspects of cancer progression. Here, we assessed the impact of VCAN expression on prognosis and the response to adjuvant therapy and immunotherapy in patients with gastric cancer (GC). METHODS: Four independ...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Junquan, Wei, Rongyuan, Huo, Shiying, Liu, Chenchen, Liu, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530562/
https://www.ncbi.nlm.nih.gov/pubmed/36203562
http://dx.doi.org/10.3389/fimmu.2022.960570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530562/
https://www.ncbi.nlm.nih.gov/pubmed/36203562
http://dx.doi.org/10.3389/fimmu.2022.960570

Ejemplares similares